Research & Development: Page 81
-
PharmaVoice Team/PharmaVoice
PharmaTrax
Expansion in size and number of clinical trials. The increase in clinical trials has been prompted by regulators seeking more extensive study data to validate drug safety. Greater numbers of postmarketing Phase IV studies and a rising level of drug development activity have also contributed to th...
By PharmaVoice Team • April 29, 2008 -
PharmaVoice Team/PharmaVoice
The Fourth Hurdle: The Call for Pharmacoeconomic Data
Managed MARKETS What began as a movement by government payers in other parts of the world is now making its mark here in the United States. Pharmacoeconomics — the scientific discipline that compares the value of one pharmaceutical drug to another to assess its value and costeffectiveness — has b...
By Denise Myshko • April 29, 2008 -
Explore the Trendline➔
Stock via Getty Images
TrendlineArtificial intelligence & machine learning
After years of excited buzz around the potential of artificial intelligence and machine learning, pharma has begun to realize the true implications and potential value of these technologies.
By PharmaVoice staff -
PharmaVoice Team/PharmaVoice
PharmaOutlet
Study Coordinator A is an early adopter of technology on the cutting edge of the next generation processes who is always eager to try something new. Study Coordinator B is a risk averse, technological laggard who subscribes to the “if it isn’t broken, don’t fix it” mantra. Herein lies one of the ...
By Gil Kampfer • April 29, 2008 -
PharmaVoice Team/PharmaVoice
UpFront
SOURCE:CEGEDIMDENDRITE,BEDMINSTER,N.J. DTC ALERT Shift to Physician Offices, Online Programs Cegedim Dendrite’s annual survey indicates DTC marketing is moving away from traditional mass media promotion. According to the survey, almost twothirds of marketers want to see more spending on emerging ...
By PharmaVoice Team • April 29, 2008 -
PharmaVoice Team/PharmaVoice
Letter from the Editor
Every month our goal is to feature thought leaders who have the ability to change the course of the industry. This month we exceeded this goal in spades. We are pleased to pay homage to the HBA’s 95 Rising Stars, some of the industry’s brightest and most talented individuals. These executive wome...
By Taren Grom • April 29, 2008 -
PharmaVoice Team/PharmaVoice
From Scorpion to Cancer
MOTHER NATURE BUILT IT, MAN IS IMPROVING IT. TransMolecular’s 131 ITM601 is a synthetic version of a peptide from the venom of scorpions combined with a radioactive iodine. In Phase I/II trials to treat glioma,a deadly form of brain cancer, the product can deliver a targeted dose of radiation to ...
By Denise Myshko • April 25, 2008 -
PharmaVoice Team/PharmaVoice
E-Media
84 F e b ru a r y 200 3 PharmaVOICE EMEDIA NEW ELECTRONIC AND WEBBASED APPLICATIONS, SITES, AND TECHNOLOGIES ProscapeTechnologies has anew Internet tool to make facetoface selling more effective. Proscape.Net provides mobile sales organizations a common technolo gy platform to exchange, update, c...
By PharmaVoice Team • April 24, 2008 -
PharmaVoice Team/PharmaVoice
What's New
WHAT’S NEW NEW HEALTHCARERELATED PRODUCTS, SERVICES, AND COMPANIES Pharmaceutical companies wanting to gain an edge in managedcare markets can turn to PharmaStrat Inc. for comprehensive market research services.The recently launched company was founded by Philip J. Patrick, a pharmaceutical execu...
By PharmaVoice Team • April 24, 2008 -
PharmaVoice Team/PharmaVoice
On the Calendar
February 10,2003,Park Hyatt San Francisco — San Francisco European Regulatory Affairs: An InDepth Review of Registration Procedures in the European Union This Drug Information Association training course will cover the evolu tion of the registration systems available for approval of products sinc...
By PharmaVoice Team • April 24, 2008 -
PharmaVoice Team/PharmaVoice
PharmaTrax
Survey Shows One Third of Americans USE ANTIBIOTICS INAPPROPRIATELY A survey conducted by Harris Interactive has revealed that one out of three Americans mistakenly believes antibiotics are effective in treating viruses such as cold and flu and takes these drugs to fight these viruses. The survey...
By PharmaVoice Team • April 24, 2008 -
PharmaVoice Team/PharmaVoice
PharmaOutlet
When launching a newproduct, marketers tend to focus on core audiences such as the physician and the patient, and on the clinical aspects of the drug, highlighting safety and clinical effectiveness. These factors are essential to a successful launch, but there are two additional fac tors that are...
By PharmaVoice Team • April 24, 2008 -
PharmaVoice Team/PharmaVoice
Letter from the Editor
PUBLISHER Lisa Banket EDITOR Taren Grom CREATIVE DIRECTOR Marah Walsh DIRECTOR OF SALES Darlene Kwiatkowski MANAGING EDITOR Denise Myshko CONTRIBUTING EDITORS Elisabeth Pena Kim Ribbink Alex Robinson Lynda Sears Copyright 2003 by PharmaLinx LLC, Titusville, NJ Printed in the U.S.A. Volume Three, ...
By PharmaVoice Team • April 24, 2008 -
PharmaVoice Team/PharmaVoice
Walt Woltosz — Quantum Leap
Walt Woltosz is using his experience with simulation software in the aerospace industry to try to transform the way pharmaceutical companies approach data gathering and research, and he’s proving that it just might take a rocket scientist to get the industry on track. WHAT DOES THE PHARMACEUTICAL...
By Kim Ribbink • April 24, 2008 -
PharmaVoice Team/PharmaVoice
Crossing the EDC Chasm
By Dr. Paul Bleicher The emergence of comprehensive eCDM solutions that can seamlessly link together traditional and electronic data management may be the technology that sponsors are still seeking. IN AN EXCLUSIVE INTERVIEW WITH PHARMAVOICE, PAUL BLEICHER, M.D., PH.D., FOUNDER, CHAIRMAN, AND CHI...
By PharmaVoice Team • April 24, 2008 -
PharmaVoice Team/PharmaVoice
E-Media
NEW ELECTRONIC AND WEB-BASED APPLICATIONS, SITES, AND TECHNOLOGIES CLINPHONE Unveils New Website ClinPhone has redesigned its Website, clinphone.com, to give it more functionality and a portal style. The site contains more product information than the previous site, including details of ClinPhone...
By PharmaVoice Team • April 22, 2008 -
PharmaVoice Team/PharmaVoice
What's New
NEW HEALTHCARE-RELATED PRODUCTS, SERVICES, AND COMPANIES DIA AND CENTERWATCH TEAM UP to Disseminate Clinical Research Information This collaborative agreement establishes an ongoing process to jointly deliver, throughout the world, a more complete continuum of practical and valuable information f...
By PharmaVoice Team • April 22, 2008 -
PharmaVoice Team/PharmaVoice
Anthony Tebbutt — A global Perspective
A Global PERSPECTIVE BY KIM RIBBINK With a diverse professional background, spanning several functions as well as several countries, Anthony Gordon Tebbutt is working to propel UCB Pharma Inc. into a billion-dollar company. A COMPANY WITH A WORLDWIDE PRESENCE AND A PEOPLEORIENTED APPROACH TO BUSI...
By Kim Ribbink • April 22, 2008 -
PharmaVoice Team/PharmaVoice
Scanning to Save Lives
To Save Lives BY ELISABETH PENA As the FDA proposes a rule to require bar coding on almost all medications and blood products, the pharmaceutical and hospital industries are moving forward with efforts to incorporate barcodes on unit-dose packages of drugs as a way to prevent hospital medication ...
By Elisabeth Pena • April 22, 2008 -
PharmaVoice Team/PharmaVoice
Is Bigger Better?
IS BIGGER BETTER? IT’S THE QUESTION THAT JUST DOESN’T GO AWAY. A larger organization may be in a better position to survive attrition for a longer period, but in an industry where innovation is expected to be the driver of success for the long term, BIGGER MAY NOT ALWAYS BE THE WAY TO GO. BY DEN...
By Denise Myshko • April 22, 2008 -
PharmaVoice Team/PharmaVoice
For Art's Sake
CREATIVE review Rich content and bold images are the keys to success for the creative teams behind this month’s selections. Industry experts have identified two ads and a Web site that get straight to the point. Regan Campbell Ward’s Gynecare ad explains what the drug treats in one powerful symbo...
By PharmaVoice Team • April 21, 2008 -
PharmaVoice Team/PharmaVoice
PharmaOutlet
Contributed by Merrill Matthews Jr., Ph.D. ANSWERING THE INDUSTRY’S CRITICS: PRICES AND PROFITS For several years, the pharmaceutical industry has been under attack by people and organizations claiming to want nothing more than to ensure people have access to affordable medicines. Although most o...
By PharmaVoice Team • April 21, 2008 -
PharmaVoice Team/PharmaVoice
Opinions
WHAT’S on your mind More on mentoring … P harmaVOICE wanted to know: Who has played a role in your professional and personal development? And does your company have a mentoring program? A Necessary Luxury Is mentoring a lost art? No. Many of us have worked for those who cared and shared, and led...
By PharmaVoice Team • April 21, 2008 -
PharmaVoice Team/PharmaVoice
Raise Your Voice: Letters
RAISE your voice LETTERS Asynchronous Discussions Online asynchronous discussions provide savings on travel, and very importantly, they make it possible to get input and dissseminate information globally in a way not previously available. — Diane Hayes, Ph.D. Market Research Recognizing the man...
By PharmaVoice Team • April 21, 2008 -
PharmaVoice Team/PharmaVoice
Spiros Jamas — A Chemical Reaction
DR.SPIROS JAMAS is leading Enanta Pharmaceuticals by tapping the company’s primary strength in its integration of chemistry and biology to tackle new targets and specific drugdevelopment challenges from all possible angles right from the start. He is relying on the hardwon lessons learned from hi...
By Kim Ribbink • April 17, 2008 -
PharmaVoice Team/PharmaVoice
What's New
aaiPharma Inc. has launched a new identity for its pharmaceutical development services division.The former AAI International has been rebranded as AAI Development Services. As part of the new identity, AAI Development Services has realigned its entire customer interface to enhance and focus the s...
By PharmaVoice Team • April 17, 2008
Previous
